Health‐related quality of life · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health economics · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality in trials using vitamin D3 (cholecalciferol) ( · adults
The intervention probably leads to lower all‐cause mortality in trials using vitamin D3 (cholecalciferol) ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular mortality in trials using vitamin D3 (cholecalciferol) ( · adults
The intervention showed no clear difference in cardiovascular mortality in trials using vitamin D3… (low certainty).
1 finding from 1 review
Intervention not reported
Cancer mortality in trials using vitamin D3 (cholecalciferol) ( · adults
The intervention probably leads to lower cancer mortality in trials using vitamin D3 (cholecalciferol) ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events: nephrolithiasis in trials using vitamin D3 combined with calcium ( · adults
The intervention probably leads to higher adverse events: nephrolithiasis in trials using vitamin D3 combined… (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events: hypercalcaemia in trials using the active forms of vitamin D (alfacalcidol and calcitriol) ( · adults
The intervention may leads to higher adverse events: hypercalcaemia in trials using the active forms of… (low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life ( · adults
1 finding from 1 review
Intervention not reported
Health economics ( · adults
1 finding from 1 review
Intervention not reported
All‐cause mortality (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in all‐cause mortality (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
Intervention not reported
Vascular mortality (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in vascular mortality (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
Intervention not reported
Myocardial infarction (fatal and non‐fatal) (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in myocardial infarction (fatal and non‐fatal) (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
Intervention not reported
Stroke (fatal and non‐fatal) (a. ticlopidine vs aspirin) (b. clopidogrel vs aspirin & dipyramidole) · patients with type 2 diabetes mellitus
The intervention probably leads to lower stroke (fatal and non‐fatal) (a. ticlopidine vs aspirin) (b.… (moderate certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Costs · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found